Clinical Trials Logo

Clinical Trial Summary

Many breast cancer patients (BCP) will gain weight during chemotherapy and about 10% of them are able to find back to their initial weight after all treatments are finished. Other studies have shown that overweight at diagnosis was associated to a twice higher risk of relapse while a weight gain during treatments increased by 30% to 50% the risk of relapse. In western countries, 75% of BCP have insufficient physical activity. Dietary and activity programs seem to be able to significantly reduce the mortality risk after breast cancer.

The investigators performed a prospective randomized trial consisting in dietary counseling, physical training and physiotherapy in hydrothermal centers. Intervention were delivered in small group session lasting 12 days. SPA cares were offered to patients. Patients in the control group also received dietary counseling given by a dietetician inside anticancer hospital, and were asked to perform more physical activities. Main endpoints of the trial addressed quality of life (SF36) one year after inclusion, weight reduction, anxiety/depression (HAD), sleep quality and long term compliance to instructions. An economic study was associated to the protocol, for volunteers only.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01563588
Study type Interventional
Source Centre Jean Perrin
Contact
Status Terminated
Phase N/A
Start date December 2008
Completion date October 2013

See also
  Status Clinical Trial Phase
Completed NCT02901223 - The Impact of Oncoplastic Breast Surgery on the Oncological Safety and Patient Satisfaction N/A
Completed NCT01220076 - Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ Phase 2